search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
115 new news items in the last 24 hours
  1. Home
  2. Health

Teplizumab, a new drug, could delay the need for insulin for patients with type 1 diabetes by up to 3 years.

Călin Nicolescu
whatsapp
facebook
linkedin
x
copy-link copy-link
8 July 2025, 08:54
main event image
Health
Foto Pixabay
google-preference

Always see our news on Google

Teplizumab, a drug already approved in the US, is being tested in the UK to slow the progression of type 1 diabetes by training the immune system to protect pancreatic cells. Hannah Robinson, the first British adult to receive the treatment, hopes it will delay the need for insulin. Experts believe the treatment represents a major change in diabetes management, with the potential to alter the immune process and help high-risk people avoid insulin therapy.

Sources

sursa imagine
Stirile ProTV
Un medicament "revoluţionar" ar putea încetini evoluţia diabetului de tip 1. Poate întârzia nevoia de insulină cu 3 ani
sursa imagine
BBC
Devon mother treated with game-changing diabetes drug
sursa imagine
independent.co.uk
Mother of two becomes the first UK patient to receive ‘groundbreaking’ new diabetes drug
sursa imagine
Hot News
Un medicament „revoluționar”, o nouă speranță pentru diabetul de tip 1. Ce așteptări au medicii

Latest News

20:28

Latvia bans the import of goods from Russia and Belarus starting September 1

20:12

Cseke Attila announced that there is no incompatibility between local/county councilors and contractual staff in the administration, contrary to circulating information.

20:09

Drought and heat hit summer crops in the EU: corn decreases by 7%, soybeans by 14%, and fodder becomes a problem in the west and center of the continent.

19:59

Tirana, the most accessible urban destination in Europe. Bucharest ranks second.

19:53

MVM Energie Romania has received ANRE authorization for the development of a photovoltaic park in Covasna. The project will be carried out on 20 hectares.

See more news

NEWS ON THE SAME TOPICS

event image
EU
A project funded by the European Union is testing 100,000 children for the early detection of type 1 diabetes.
event image
Health
An experimental injection against cancer completely eliminated tumors in patients who did not respond to chemotherapy or immunotherapy.
event image
Health
Cats could benefit from weight loss medications. The first tests are already underway.
event image
Health
WHO begins clinical study for an antiviral drug against Ebola
event image
Health
France will start partial reimbursement of treatments for obesity from June, thus becoming the first state in the EU to subsidize these medications.
event image
International
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
diabetes medically Teplizumab

Editor’s Recommendations

main event image
Current Affairs
1 hour ago

The director of Nuclearelectrica, Cosmin Ghiță, resigns from his position.

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+1
main event image
International
1 hour ago

CIA Director, John Ratcliffe, is said to have secretly arrived in Moscow aboard an American military plane.

Sources
imagine sursa
imagine sursa
imagine sursa
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol